top of page
Discover
The Latest From Our PRN Community
Welcome to our blog by PRN members for PRN members, filled with unique and engaging content to explore, connect, and engage with the world of ambulatory care pharmacy!

Search


Exploring Glucagon-like Peptide-1 receptor agonist (GLP-1 RA) Use in Patients with Cirrhosis
Written by Braylee Wardwell, PharmD and Marissa Salvo, PharmD, BCACP, FCPA, FCCP What is Cirrhosis? Cirrhosis is a condition where...
Jul 24 min read
Â
Â
Â


Emergence of SGLT-2 Inhibitor-Induced Myopathy
Written by Qabas Al-Jobori, PharmD Candidate and Adenike Atanda, PharmD, BCACP, CDCES, CTTS Â Drug-induced myopathy manifests as myalgia,...
Jun 64 min read
Â
Â
Â


Relieving the Pressure: Pulmonary Arterial Hypertension Treatment Review and Updates
Written by Kellie Ball, PharmD, MPH, BCACP and Danielle Dennis, PharmD, BCPS What is Pulmonary Hypertension (PH)? Â PH is a complex,...
Dec 19, 20245 min read
Â
Â
Â


What’s on the Menu? Nutrition Guidance for Patients with Diabetes
By Wiam Ouahab, PharmD Candidate 2025 and Helen Berlie, BHS, PharmD, BCACP Introduction Medical nutrition therapy (MNT) is essential to...
Dec 6, 20244 min read
Â
Â
Â


From Imposter to Empowered: Overcoming Imposter Syndrome for You and Your Learners
By Megan Makovsky, PharmD Candidate 2025; Nikki Polivka, PharmD Candidate 2025; Kimmy Nguyen, PharmD, BCACP, BC-ADM, TTS Have you ever...
Nov 12, 20244 min read
Â
Â
Â


Pharmacist-driven Treatment of Latent Tuberculosis Infection within a Gastroenterology Clinic: A Focus on Patients Requiring High Risk Medication Therapy or Those with Elevated Liver Enzymes
By Sarah Rinehart, PharmD, BCACP Patients with inflammatory bowel disease (IBD) are often treated with biologics or small molecules,...
Oct 17, 20245 min read
Â
Â
Â


Exploring Practice Barriers for Psychiatric Pharmacists to Address a Specialty Need
By Alexis Richardson, PharmD Candidate and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES It is estimated that 20% of adults in the United...
Aug 19, 20245 min read
Â
Â
Â


The Role of GLP-1 Receptor Agonists in Patients with Type 2 Diabetes and Diabetic Kidney Disease – Overview and Updates
By Andrea Lenear, PharmD Candidate 2025 and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES What is Diabetic Kidney Disease? Chronic kidney...
Jul 22, 20246 min read
Â
Â
Â


The Pharmacist’s Role in Hypertrophic Obstructive Cardiomyopathy
By Dave Ferris, PharmD Hypertrophic Obstructive Cardiomyopathy (HOCM) is a devastating disease and, until recently, had no treatment. ...
Jun 21, 20244 min read
Â
Â
Â


Running on Empty: Navigating the GLP-1 and GIP/GLP-1 Receptor Agonist Drug Shortage
By Sydnie Twillmann, PharmD Glucagon-like peptide 1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide...
May 27, 20244 min read
Â
Â
Â


ACCESS is Key: Providing Care for Underserved Populations
By Hannah Vitale, PharmD Candidate 2024 and Kimmy Nguyen, PharmD, BCACP, BC-ADM, TTS Introduction In the US, there are over 1,400...
Nov 21, 20234 min read
Â
Â
Â


Advancement in Technology: SmartWatch
By Devon Hess, MBA, PharmD Candidate 2024 and Rachel Long, PharmD, BCPS, CPP, CDCES Advancements in technology have revolutionized...
Nov 6, 20234 min read
Â
Â
Â


Are You Up for the Challenge? Updates on Beta-Lactam Allergies
By Kayla C. Godfrey, PharmD and Deanna McDanel, PharmD, BCPS, BCACP Introduction Penicillin allergies are reported by approximately 10%...
Oct 15, 20234 min read
Â
Â
Â


Empagliflozin in Patients with Chronic Kidney Disease - EMPA-KIDNEY 2023
By Reham Awad, PharmD, BCPS and Mukti Patel, PharmD Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were originally...
Sep 24, 20234 min read
Â
Â
Â


Occupation Influenced Diabetes
By Dallas Collins, PharmD Candidate 2024 and Adenike Atanda, PharmD, BCACP, CDCES, CTTS According to the CDC’s National Diabetes...
Sep 9, 20235 min read
Â
Â
Â


Impact of Depression on Type II Diabetes Management
By Faith Spivey, PharmD Candidate 2024 and Adenike Atanda, PharmD, BCACP, CDCES, CTTS Type II diabetes (T2DM) in the United States...
Aug 6, 20234 min read
Â
Â
Â


Changes in AHA/ACC/HFSA Guideline for Management for Heart Failure
By Jiya Thomas, PharmD and Adenike Atanda, PharmD, BCACP, CDCES, CTTS Introduction The AHA/ACC/HFSA guideline for the management of heart...
Jul 7, 20233 min read
Â
Â
Â


DRESS Head to Toe: Patient Case of Drug Reaction with Eosinophilia and Systemic Symptoms
By Madison Abbs, PharmD and Alexandria Taylor, PharmD, BCPS Patient Case: Patient is a 23-year-old female presenting to the emergency...
Jun 25, 20234 min read
Â
Â
Â


Pharmacists and Hepatitis C: From Specialty to Primary Care
By Zach Krauss, PharmD and Sarah Leupold, PharmD Hepatitis C Virus (HCV) is a viral infection that causes liver inflammation, sometimes...
May 26, 20234 min read
Â
Â
Â


Tackling Type 2 Diabetes Mellitus: 2023 ADA Pharmacologic Approaches to Glycemic Treatment Updates
By Justin Ramnarain, PharmD; Claudette Donatien, PharmD; Sami Barakat, PharmD; Rebecca Khaimova, PharmD, BCACP, CDCES Introduction In...
Mar 30, 20235 min read
Â
Â
Â
bottom of page